Compound Detail
CHEMBL4796878
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4796878 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CHILTJQKWSSOCV-JTQLQIEISA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
262.3
MW (Da)
2.63
ALogP
3
HBA
1
HBD
58.6
PSA (Ų)
0.89
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.8
IC50 1 meas. best 4.19
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 1576.0 | nM | 5.8 | Anti-HIV-1 activity against HTLV-3B infected in human MT2 cells assessed as redu... | 31893549 |
| Unchecked | IC50 | = | 64000.0 | nM | 4.19 | Inhibition of wild type recombinant HIV-1 subtype B BH10 p66/p51 reverse transcr... | 31893549 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31893549 | 10.1016/j.ejmech.2019.111987 | Unchecked | 7 |
| 31893549 | 10.1016/j.ejmech.2019.111987 | MT2 | 1 |
Data from ChEMBL 36 via Core Engine